{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:22:44Z","timestamp":1791958964632,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009446","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T00:00:00Z","timestamp":1400457600000}}],"reference-count":134,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T00:00:00Z","timestamp":1400457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T00:00:00Z","timestamp":1400457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009446.pub2","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T05:37:05Z","timestamp":1400477825000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp"],"prefix":"10.1002","volume":"2017","author":[{"given":"Helena","family":"Kastarinen","sequence":"first","affiliation":[{"name":"Finnish Medicines Agency Fimea; Assessment of Pharmacotherapies; P.O. Box 55 Fimea Finland 00034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Oksanen","sequence":"additional","affiliation":[{"name":"Finnish Medicines Agency Fimea; Assessment of Pharmacotherapies; P.O. Box 55 Fimea Finland 00034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enembe O","family":"Okokon","sequence":"additional","affiliation":[{"name":"University of Calabar Teaching Hospital; Department of Community Medicine; 13 Mbukpa Road Calabar Cross River State Nigeria 540001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa V","family":"Kiviniemi","sequence":"additional","affiliation":[{"name":"Finnish Medicines Agency; Assessment of Pharmacotherapies; Microkatu 1 Kuopio Finland 70210"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Airola","sequence":"additional","affiliation":[{"name":"Finnish Medicines Agency Fimea; Assessment of Medicinal Products; P.O. Box 55 Fimea Finland 00034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Jyrkk\u00e4","sequence":"additional","affiliation":[{"name":"Finnish Medicines Agency Fimea; Assessment of Pharmacotherapies; P.O. Box 55 Fimea Finland 00034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Oravilahti","sequence":"additional","affiliation":[{"name":"Finnish Medicines Agency Fimea; Assessment of Pharmacotherapies; P.O. Box 55 Fimea Finland 00034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piia K","family":"Rannanheimo","sequence":"additional","affiliation":[{"name":"Finnish Medicines Agency Fimea; Assessment of Pharmacotherapies; P.O. Box 55 Fimea Finland 00034"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H","family":"Verbeek","sequence":"additional","affiliation":[{"name":"Finnish Institute of Occupational Health; Cochrane Work Review Group; PO Box 310 Kuopio Finland 70101"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,19]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/09546639209088720","article-title":"Clotrimazole-hydrocortisone, hydrocortisone and propylene glycol liniment in the treatment of seborrhoeic dermatitis of the scalp","volume":"3","author":"Attila","year":"1992","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1468-3083.2001.00193-9.x","article-title":"Comparative effects of calcipotriol and betamethasone 17-valerate solution in the treatment of seborrhoeic dermatitis of the scalp","volume":"15","author":"Basak","year":"2001","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/09546630802687349","article-title":"Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study","volume":"20","author":"Cicek","year":"2009","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0004|cit4","first-page":"260","article-title":"Atrophogenic potential of alclometasone dipropionate ointment 0.05% vs hydrocortisone ointment 1.0%","volume":"39","author":"Cornell","year":"1986","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0005|cit5","first-page":"577","article-title":"Comparison of the efficacy and safety of amcinonide lotion 0.1% with those of betamethasone valerate lotion 0.1% in patients with seborrheic dermatitis","volume":"46","author":"Cornell","year":"1989","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0011-393X(05)80194-8","article-title":"Dermal safety comparison of 0.05% desonide cream and 1.0% hydrocortisone cream","volume":"53","author":"Cornell","year":"1993","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0007|cit7","first-page":"549","article-title":"Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo","volume":"12","author":"Dreno","year":"2002","journal-title":"European Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009446.pub2-BIB0008|cit8","first-page":"153","article-title":"Lithium gluconate 8% ointment in the treatment of moderate to severe seborrhoeic dermatitis","volume":"16","author":"Dreno","year":"2002","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0010|cit9","first-page":"S696","article-title":"Lithium vs ketoconazole in seborrheic dermatitis: a multicenter, randomized, controlled study","volume":"129","author":"Dreno","year":"2002","journal-title":"Annales of Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0009|cit10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1365-2133.2003.05328.x","article-title":"Lithium gluconate 8% vs. ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study","volume":"148","author":"Dreno","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD009446.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.clindermatol.2009.09.002","article-title":"An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face","volume":"27","author":"Elewski","year":"2009","journal-title":"Clinics in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2133.1986.tb04878.x","article-title":"Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone","volume":"114","author":"Faergemann","year":"1986","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD009446.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archderm.142.8.1066","article-title":"Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0014|cit14","first-page":"70","article-title":"A comparison between hydrocortisone 17-butyrate and betamethasone 17\u03b1-valerate in seborrhoeic dermatitis of the scalp","volume":"6","author":"Fredriksson","year":"1978","journal-title":"IRCS Medical Science: Clinical Medicine; Clinical Pharmacology and Therapeutics; Connective Tissue, Skin and Bone"},{"issue":"1368","key":"10.1002\/14651858.CD009446.pub2-BIB0015|cit15","first-page":"1178","article-title":"Topical corticosteroids in seborrhoeic dermatitis. A report from the general practitioner research group","volume":"226","author":"General Practitioner Research Group","year":"1982","journal-title":"Practitioner"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0016|cit16","first-page":"607","article-title":"A study to compare the efficacy of hydrocortisone 17-butyrate (Locoid) 0.1% scalp lotion and betamethasone 17-valerage (Betnovate) 0.1% lotion in the treatment of seborrhoeic dermatitis of the scalp","volume":"26","author":"Gip","year":"1979","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"9","key":"10.1002\/14651858.CD009446.pub2-BIB0017|cit17","first-page":"638","article-title":"A national double-blind clinical trial of a new corticosteroid lotion: a 12-investigator cooperative analysis","volume":"14","author":"Harris","year":"1972","journal-title":"Current therapeutic research, clinical & experimental"},{"issue":"7","key":"10.1002\/14651858.CD009446.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0011-393X(96)80061-0","article-title":"Mometasone furoate solution 0.1% compared with ketoconazole shampoo 2% for seborrheic dermatitis of the scalp","volume":"57","author":"Hersle","year":"1996","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2133.1989.tb01429.x","article-title":"A double-blind trial of treatment of seborrheic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream","volume":"121","author":"Katsambas","year":"1989","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09546630802286993","article-title":"An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis","volume":"20","author":"Koc","year":"2009","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0021|cit21","first-page":"723","article-title":"A double-blind comparison of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of seborrheic dermatitis","volume":"51","author":"Kousidou","year":"1992","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2230.1997.tb01071.x","article-title":"Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis","volume":"22","author":"Langtry","year":"1997","journal-title":"Clinical & Experimental Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0023|cit23","first-page":"313","article-title":"Treatment of seborrhoeic dermatitis of the scalp. Report of a double-blind comparative trial of hydrocortisone 17-butyrate 0.1% lotion (Locoid) and betamethasone 17,21-Dipropionate 0.05% Lotion (Diproderm)","volume":"20","author":"Ludvigsen","year":"1983","journal-title":"Clinical Trials Journal"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0024|cit24","first-page":"304","article-title":"Amcinonide lotion 0.1% in the treatment of patients with seborrheic dermatitis of the scalp and\/or other hairy areas","volume":"44","author":"Lynfield","year":"1988","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09546639209088705","article-title":"Mometasone furoate cream 0.1% vs. hydrocortisone cream 1% in the treatment of seborrhoeic dermatitis","volume":"3","author":"Medansky","year":"1992","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000247566","article-title":"Comparative Study of Ketoconazole 2% Foaming Gel and Betamethasone Dipropionate 0,05% Lotion in the Treatment of Seborrhoeic Dermatitis in Adults","volume":"184","author":"Ortonne","year":"1992","journal-title":"Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.2011.10269.x","article-title":"Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study","volume":"165","author":"Ortonne","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2011.02.032","article-title":"Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults","volume":"67","author":"Papp","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Pari T Pulimood S Jacob M George S Jeyaseelan L Thomas K Randomized double blind controlled trial 2% ketoconazole cream versus 0,05% clobetasol 17-butyrate cream in seborrhoeic dermatitis Journal of the European Academy of Dermatology & Venereology 1998 89 90","DOI":"10.1111\/j.1468-3083.1998.tb00938.x"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09546639209088704","article-title":"Treatment of dandruff with a ketoconazole 2% shampoo","volume":"3","author":"Piepponen","year":"1992","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/09546639309080552","article-title":"Double-blind placebo-controlled multicentre study of fluocinolone acetonide shampoo (FS Shampoo) in scalp seborrhoeic dermatitis","volume":"4","author":"Ramirez","year":"1993","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0032|cit32","first-page":"397","article-title":"Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study","volume":"79","author":"Reygagne","year":"2007","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2133.2004.06208.x","article-title":"Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial","volume":"151","author":"Rigopoulos","year":"2004","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0034|cit34","first-page":"320","article-title":"Seborrheic Dermatitis of the Face - Treated with Fluocinolone Acetonide Solution: A Double Blind Study","volume":"6","author":"Rudner","year":"1970","journal-title":"Cutis"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1346-8138.2009.00607.x","article-title":"Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study","volume":"36","author":"Shin","year":"2009","journal-title":"Journal of Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD009446.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0190-9622(88)70244-3","article-title":"Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study","volume":"19","author":"Stratigos","year":"1988","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/09546639809160702","article-title":"Betamethasone-17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults. Results of a Dutch multicenter study","volume":"9","author":"Van't Veen","year":"1998","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.11.007","article-title":"Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis","volume":"57","author":"Warshaw","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0039|cit39","first-page":"270","article-title":"Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases","volume":"60","author":"Aertgeerts","year":"1985","journal-title":"Zeitschrift f\u00fcr Hautkrankheiten"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009446.pub2-BIB0040|cit40","first-page":"88","article-title":"Berlin Multicenter Study on Prednicarbate Preparations in Dermatologic Practices","volume":"61","author":"Albrecht","year":"1986","journal-title":"Zeitschrift f\u00fcr Hautkrankheiten"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0041|cit41","first-page":"95","article-title":"A report of clinical trial conducted on Toto ointment and soap products","volume":"95","author":"Alebiosu","year":"2003","journal-title":"Journal of the National Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.1967.tb11462.x","article-title":"Do shampoos affect dandruff?","volume":"79","author":"Alexander","year":"1967","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09546639409084551","article-title":"Clinical efficacy of Polytar AF (Fongitar) and Nizoral scalp treatments in patients with dandruff\/seborrhoeic dermatitis","volume":"5","author":"Amos","year":"1994","journal-title":"Journal of Dermatological Treatment"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD009446.pub2-BIB0044|cit44","first-page":"1","article-title":"Management of seborrhoic dermatitis","volume":"45","author":"Anonymous","year":"1994","journal-title":"Der Hautarzt"},{"issue":"18","key":"10.1002\/14651858.CD009446.pub2-BIB0045|cit45","first-page":"1032","article-title":"Seborrheic dermatitis: Lithium deprives the growth basis of yeast fungus","volume":"44","author":"Anonymous","year":"1994","journal-title":"Therapiewoche"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0046|cit46","first-page":"157","article-title":"Double blind and aleatory study to evaluate efficacy of icthiol\/octopirox\/salicilic acid in seborrehic dermatitis","volume":"43","author":"Arenas","year":"1999","journal-title":"Dermatologia Revista Mexicana"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0047|cit47","first-page":"477","article-title":"Comparing the efficacy of emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: a clinical trial","volume":"18","author":"Attarzadeh","year":"2013","journal-title":"Journal of Research in Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0048|cit48","first-page":"209","article-title":"Evaluation of furacin-s (nitrofurazone and hydrocortisone acetate) in the treatment of different dermatoses","volume":"41","author":"Banerjee","year":"1975","journal-title":"Indian Journal of Dermatology, Venerology & Leprology"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1358\/mf.2005.27.4.893581","article-title":"Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability","volume":"27","author":"Barbanoj","year":"2005","journal-title":"Methods & Findings in Experimental & Clinical Pharmacology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009446.pub2-BIB0050|cit50","first-page":"S295","article-title":"Comparative effects of calcipotriol and betamethasone 17-valerate in seborrhoeic dermatitis of the scalp [Abstract P-547]. The 8th Congress of the European Academy of Dermatology and Venereology. Amsterdam, The Netherlands 29thSept-3rd October 1999","volume":"12","author":"Ba\u015fak","year":"1999","journal-title":"Journal of European Adacemy of Dermatology and Venereology"},{"issue":"15","key":"10.1002\/14651858.CD009446.pub2-BIB0051|cit51","first-page":"706","article-title":"A new topical corticosteroid. Its evaluation in a double-blind trial","volume":"89","author":"Bertamino","year":"1975","journal-title":"Riforma Medica"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0052|cit52","first-page":"35","article-title":"Comparison of fluocinonide in a double-blind study with betamethasone valerate","volume":"14","author":"Binder","year":"1972","journal-title":"Current Therapeutic Research"},{"issue":"6512","key":"10.1002\/14651858.CD009446.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.292.6512.28","article-title":"Use of topical lithium succinate for seborrhoeic dermatitis","volume":"292","author":"Boyle","year":"1986","journal-title":"British Medical Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009446.pub2-BIB0054|cit54","first-page":"21","article-title":"Clinical testing of a new local corticoid: desoxymethasone","volume":"50","author":"Camarasa","year":"1975","journal-title":"Zeitschrift f\u00fcr Hautkrankheiten"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0055|cit55","first-page":"V","article-title":"Clinical observations on two new liquid forms of clobetasol propionate in seborrhoeic eczema","volume":"117","author":"Carboni","year":"1982","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0056|cit56","first-page":"27","article-title":"Lithium in seborrheic dermatitis","volume":"8","author":"Christodoulou","year":"1983","journal-title":"Psychiatric Journal of the University of Ottawa"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000247539","article-title":"Use of topical lithium succinate in the treatment of seborrhoeic dermatitis","volume":"184","author":"Cuelenaere","year":"1992","journal-title":"Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/09546639009086733","article-title":"A comparative study of betamethasone dipropionate with salicylic acid and betamethasone valerate for the treatment of steroid-responsive dermatoses of the scalp","volume":"1","author":"Curley","year":"1990","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09546639909056025","article-title":"Comparative efficacy of shampoos containing coal tar (4.0% w\/W;TarmedTM), coal tar (4.0% w\/w) plus ciclopirox olamine (1.0% w\/w; TarmedTM AF) and ketoconazole (2.0% w\/w; Nizoral\u00ae) for the treatment of dandruff\/seborrhoeic dermatitis","volume":"10","author":"Davies","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/030006058401200508","article-title":"Halomethasone (C 48.401-Ba) for the Topical Treatment of Common Dermatoses","volume":"12","author":"Brassine","year":"1984","journal-title":"Journal of International Medical Research"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009446.pub2-BIB0061|cit61","first-page":"342","article-title":"Study of four antidandruff shampoos therapeutic effectiveness [Abstract P25-7]. The 12th Congress of the European Academy of Dermatology and Venereology Barcelona, Spain 15-18th October 2003","volume":"17","author":"Dobrev","year":"2003","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0062|cit62","first-page":"333","article-title":"Safe and effective treatment of seborrheic dermatitis","volume":"83","author":"Elewski","year":"2009","journal-title":"Cutis"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/030006058301100208","article-title":"Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses","volume":"11","author":"Elie","year":"1983","journal-title":"Journal of International Medical Research"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD009446.pub2-BIB0064|cit64","first-page":"AB47","article-title":"Clinical efficacies of topical agents for the treatment of seborrheic dermatitis on the scalp. 67th Annual Meeting of the American Academy of Dermatology, AAD San Francisco, CA United States. Conference Start: 20090306 Conference End: 20090310","volume":"60","author":"Eun","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD009446.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-4362.2000.00986-4.x","article-title":"Clobetasol propionate foam 0.05%: A novel vehicle with enhanced delivery","volume":"39","author":"Franz","year":"2000","journal-title":"International Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0066|cit66","first-page":"324","article-title":"Investigations of a new synthetic steroid, betamethasone-17, 21-dipropionate, in alcoholic solution","volume":"18","author":"Fredriksson","year":"1975","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0067|cit67","first-page":"25","article-title":"Controlled comparison of Clinitar Shampoo and Selsun Shampoo in the treatment of seborrhoeic dermatitis of the scalp","volume":"39","author":"Fredriksson","year":"1985","journal-title":"British Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1440-0960.2002.00592.x","article-title":"Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen\u00ae) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis","volume":"43","author":"Freeman","year":"2002","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0069|cit69","first-page":"155","article-title":"Topical application of 8% Lithiumsuccinat and 0.05% Zincsulfate in seborrhoic Dermatitis.","volume":"70","author":"Fritz","year":"1995","journal-title":"H + G Zeitschrift Fur Hautkrankheiten"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0070|cit70","first-page":"327","article-title":"Evaluation of efficacy of antidandruff agents","volume":"32","author":"Futterer","year":"1981","journal-title":"Journal of the Society of Cosmetic Chemists of Japan"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0071|cit71","first-page":"243","article-title":"The use of a pale type of Ichthyol in cosmetic dermatology. Cosmetic, single-centre, controlled and randomized double blind study for proof of efficacy and tolerance of a combination of Ichthyol Pale 0.5% and ketoconazole 0.5% vs. ketoconazole 1.0% shampoo in treatment of moderate to severe dandruff","volume":"8","author":"Gayko","year":"2006","journal-title":"Dermatologia Kliniczna"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archderm.1973.01620210038010","article-title":"A Clinical Evaluation of 0.05% Desonide Cream. A New Nonfluorinated Topical Corticosteroid","volume":"107","author":"Gentry","year":"1973","journal-title":"Archives in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09546639609089551","article-title":"Antidandruff shampoos and the stratum corneum","volume":"7","author":"Goffin","year":"1996","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0074|cit74","first-page":"27","article-title":"Topical lithium succinate - a safe and effective treatment for seborrhoeic dermatitis in adults","volume":"119","author":"Gould","year":"1988","journal-title":"International Pharmaceutical Abstracts British Journal of Dermatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009446.pub2-BIB0075|cit75","first-page":"94","article-title":"A comparative efficacy study of two dandruff shampoos [Abstract 1206]. The 19th World Congress of Dermatology 15-20 June, 1997 Sydney, Australia","volume":"38","author":"Grossman","year":"1997","journal-title":"Australasian Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaad.2006.01.011","article-title":"Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation","volume":"54","author":"High","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0077|cit77","first-page":"1071","article-title":"A comparison of two sulfur and salicylic acid shampoos in the treatment of dandruff","volume":"44","author":"Hochman","year":"1988","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0078|cit78","first-page":"1S454","article-title":"Efficacy and tolerability of a new shampoo in the treatment of dandruff [Abstract PO425]. 20th World Congress of Dermatology Paris 1st to 5th July 2002","volume":"129","author":"Humke","year":"2002","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"9","key":"10.1002\/14651858.CD009446.pub2-BIB0079|cit79","first-page":"1130","article-title":"Hydrocortisone Alcohol in the Treatment of Seborrheic Dermatitis","volume":"5","author":"Jacksonville Dermatology Society","year":"1969","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Jafferany M Lithium and skin: dermatologic manifestations of lithium therapy International Journal of Dermatology 2008 1101 11","DOI":"10.1111\/j.1365-4632.2008.03873.x"},{"issue":"1\/2","key":"10.1002\/14651858.CD009446.pub2-BIB0081|cit81","first-page":"33","article-title":"Comparative double-blind, randomized zinc pyrithion 1.5 shampoo in the treatment of dandruff","volume":"13","author":"Jaramillo Antill\u00f3n","year":"1992","journal-title":"Revista Costarricense de Ciencias Medicas"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0082|cit82","first-page":"302","article-title":"Seborrheic eczema responds more quickly to treatment with pimecrolimus cream than treatment with ketoconazole cream. 36th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung, ADF Heidelberg Germany. Conference Start: 20090305 Conference End: 20090307","volume":"18","author":"Jensen","year":"2009","journal-title":"Experimental Dermatology"},{"issue":"Issue S2","key":"10.1002\/14651858.CD009446.pub2-BIB0083|cit83","first-page":"S69","article-title":"Pimecrolimus Cream Treatment Normalizes Clinical Symptoms, Skin Barrier Function and Antimicrobial Protein Expression in Seborrheic Eczema. 40th Annual Meeting of the European Society for Dermatological Research Helsinki Finland. Conference Start: 20100908 Conference End: 20100911","volume":"130","author":"Jensen","year":"2010","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0084|cit84","first-page":"1S758","article-title":"Clinical efficacy of a unique 10% sulfacetamide lotion in patients with seborrheic dermatitis of the scalp [Abstract P1982]. 20th World Congress of Dermatology Paris 1st to 5th July 2002","volume":"129","author":"Kaminester","year":"2002","journal-title":"Annales de Dermatologie et de Venereologie"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0085|cit85","first-page":"97","article-title":"New innovations in anti-dandruff technology: Proteomics application [Abstract]. 1st Eastern Asia Dermatology Congress, EADC2010 Fukuoka Japan. Conference Start: 20100930 Conference End: 20101003","volume":"37","author":"Karsono","year":"2010","journal-title":"Journal of Dermatology"},{"issue":"Suppl","key":"10.1002\/14651858.CD009446.pub2-BIB0086|cit86","first-page":"19","article-title":"How frequently should 0.1% tacrolimus ointment be used to reduce exacerbation of stabilised adult facial seborrhoeic dermatitis? Results from a randomised, double-blind, vehicle-controlled, multi-centre trial [Abstract]. 2nd Eastern Asia Dermatology Congress Beijing China. Conference Start: 20120613 Conference End: 20120615","volume":"39","author":"Kim","year":"2012","journal-title":"Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2340\/00015555-1532","article-title":"Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial","volume":"93","author":"Kim","year":"2013","journal-title":"Acta Dermato-Venereologica"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD009446.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.clindermatol.2009.09.004","article-title":"An open-label, single-center pilot study to determine the antifungal activity of a new nonsteroidal cream (Promiseb Topical Cream) after 7 days of use in healthy volunteers","volume":"27","author":"Kircik","year":"2009","journal-title":"Clinics in Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD009446.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/milmed\/139.9.728","article-title":"Double-Blind Trial of a New Topical Corticosteroid in a US Naval Hospital","volume":"139","author":"Levy","year":"1974","journal-title":"Military Medicine"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0090|cit90","first-page":"290","article-title":"Observations to the curative effects in the treatment of 120 cases of seborrhoeic dermatitis and pityriasis capitis with triatop and coal tar lotion","volume":"29","author":"Li","year":"2000","journal-title":"Journal of Clinical Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.det.2010.03.008","article-title":"Innovative use of topical calcineurin inhibitors","volume":"28","author":"Lin","year":"2010","journal-title":"Dermatologic Clinics"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0092|cit92","first-page":"190","article-title":"Ketoconazole 1% shampoo vs climbazole shampoo on the treatment of seborrhoeic dermatitis in scalp skin","volume":"40","author":"L\u00f3pez Padilla","year":"1996","journal-title":"Dermatolog\u00eda Revista Mexina"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0093|cit93","first-page":"98","article-title":"The clinical observation of 901 cases multi-effective lotion for scalp steatorrhea dermatitis (Chinese)","volume":"7","author":"Luo","year":"1993","journal-title":"Chinese Journal of Dermatovenereology"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2340\/0001555554373375","article-title":"The effect of betamethasone valerate on seborrhoeic dermatitis of the scalp. A clinical, histopathological and cell kinetic study","volume":"54","author":"Marks","year":"1974","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Mensing CO Mensing CH Mensing H Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck International Journal of Dermatology 2008 960 4","DOI":"10.1111\/j.1365-4632.2008.03634.x"},{"issue":"37","key":"10.1002\/14651858.CD009446.pub2-BIB0096|cit96","first-page":"1679","article-title":"Betamethasone-17,21-dipropionate plus salicylic acid compared with betamethasone-dipropionate solution in the therapy of erythemato-squamous dermatoses","volume":"101","author":"Nolting","year":"1983","journal-title":"Fortschritte der Medizin"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0097|cit97","first-page":"140","article-title":"Treatment with topical corticosteroids in severe or resistant dermatoses","volume":"33","author":"Nolting","year":"1985","journal-title":"Dermatosen in Beruf und Umwelt"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009446.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/0926-9959(95)96394-N","article-title":"Subjects using anti-dandruff shampoos","volume":"5","author":"Pierard-Franchimont","year":"1995","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0099|cit99","first-page":"S305","article-title":"Comparative anti-dandruff efficacy between a tar and a non-tar shampoo","volume":"12","author":"Pierard-Franchimont","year":"1999","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD009446.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000018362","article-title":"Comparative anti-dandruff efficacy between a tar and a non-tar shampoo","volume":"200","author":"Pierard-Franchimont","year":"2000","journal-title":"Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1467-2494.2002.00145.x","article-title":"Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations","volume":"24","author":"Pierard-Franchimont","year":"2002","journal-title":"International Journal of Cosmetic Science"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000063382","article-title":"A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis","volume":"204","author":"Pierard-Franchimont","year":"2002","journal-title":"Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000066452","article-title":"A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis","volume":"15","author":"Pierard-Franchimont","year":"2002","journal-title":"Skin Pharmacology & Applied Skin Physiology"},{"issue":"38","key":"10.1002\/14651858.CD009446.pub2-BIB0104|cit104","first-page":"555","article-title":"Clinical experiences with fluocinonide FAPG","volume":"123","author":"Reiffenstuhl","year":"1973","journal-title":"Wiener Medizinische Wochenschrift"},{"issue":"7","key":"10.1002\/14651858.CD009446.pub2-BIB0105|cit105","first-page":"267","article-title":"Comparative studies with halcinonide and fluocortolone in local administration","volume":"49","author":"Reinhard","year":"1974","journal-title":"Zeitschrift f\u00fcr Hautkrankheiten"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0106|cit106","first-page":"311","article-title":"A Study on the Effectiveness of Clocortolone Pivalate (Purantix\u00ae) Cream on Certain Common Skin diseases","volume":"16","author":"Sohn","year":"1978","journal-title":"Korean Journal of Dermatology"},{"issue":"15","key":"10.1002\/14651858.CD009446.pub2-BIB0107|cit107","first-page":"247","article-title":"Clinical effectiveness of fluocinonide in several skin diseases","volume":"123","author":"Tomoka","year":"1973","journal-title":"Wiener medizinische Wochenschrift"},{"issue":"718","key":"10.1002\/14651858.CD009446.pub2-BIB0108|cit108","first-page":"738","article-title":"Locoid vs Betnovate lotion in the treatment of seborrhoeic and atopic dermatitis of the scalp","volume":"95","author":"Turnbull","year":"1982","journal-title":"New Zealand Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2230.1980.tb01665.x","article-title":"Seborrhoeic dermatitis of the scalp treated with a tar\/zinc pyrithione shampoo","volume":"5","author":"Veien","year":"1980","journal-title":"Clinical & Experimental Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0110|cit110","first-page":"84","article-title":"Treatment of seborrhoeic dermatitis and other disorders of the scalp requiring corticosteroids using alclometasone dipropionate 0.05% solution. Results of a double-blind-study","volume":"15","author":"Wacker","year":"1989","journal-title":"Aktuelle Dermatologie"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD009446.pub2-BIB0111|cit111","first-page":"AB50","article-title":"A novel foam vehicle is consistently preferred by patients for dermatologic conditions [Abstract]. 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204 Conference End: 20110208","volume":"64","author":"Weiss","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"14","key":"10.1002\/14651858.CD009446.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1517\/14656566.7.14.1967","article-title":"Topical pimecrolimus for skin disease other than atopic dermatitis","volume":"7","author":"Wollina","year":"2006","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00128071-200708030-00003","article-title":"The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis","volume":"8","author":"Wollina","year":"2007","journal-title":"American Journal of Clinical Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009446.pub2-BIB0114|cit114","first-page":"1","article-title":"An Overview of International Clinical Trials with Halometasone Cream","volume":"11","author":"Yawalkar","year":"1983","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0115|cit115","first-page":"765","article-title":"Treatment of seborrheic dermatitis: double-blind studies comparing dexamethasone 0.012% and fluocinolone acetonide 0.01%","volume":"15","author":"Fredriksson","year":"1975","journal-title":"Cutis"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0116|cit116","first-page":"68","article-title":"A double blind evaluation of fluocinolone acetonide solution in the treatment of seborrheic dermatitis of the face","volume":"72","author":"Snyder","year":"1969","journal-title":"Pennsylvania Medicine"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0117|cit117","unstructured":"2005-006208-21 Clinical Efficacy of Pimecrolimus Cream in Seborrheic Dermatitis. Efficacy of pimecrolimus in normalizing clinical symptoms, explorative study of barrier function, hydration, lipid content and differentiation in seborrheic dermatitis: a randomized, double-blind study in adults with seborrheic dermatitis treated with 1 % pimecrolimus cream versus 2 % ketoconazole cream as control www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2005-006208-21"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0118|cit118","unstructured":"2006-003984-30 A multicenter, randomized, double-blind, two-arm, vehicle-controlled, parallel-group, two stage study to evaluate and demonstrate the efficacy and to evaluate the safety of pimecrolimus 1% cream in the treatment of seborrhoeic dermatitis in patients 12 years of age and older www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2006-003984-30"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0119|cit119","unstructured":"2007-007088-25 Inflammatory seborrhoeic dermatitis of the scalp in adult www.clinicaltrialsregister.eu\/ctr-search\/search?query=2007-007088-25"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0120|cit120","unstructured":"2009-013120-23 Efficacy and safety of LBC 45 (lithium gluconate) for the treatment of seborrhoeic dermatitis of the scalp www.clinicaltrialsregister.eu\/ctr-search\/search?query=2009-013120-23"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0121|cit121","unstructured":"2010-022861-93 Confirmation of th efficacy and safety of LBC 45 (lithium gluconate) for the treatment of seborrhoeic dermatitis of the scalp www.clinicaltrialsregister.eu\/ctr-search\/search?query=2010-022861-93"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0122|cit122","unstructured":"NCT00403559 A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis clinicaltrials.gov\/ct2\/show\/NCT00403559"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0123|cit123","unstructured":"NCT01011621 Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis clinicaltrials.gov\/ct2\/show\/study\/NCT01011621"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/ecp.11.68","article-title":"Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials.","volume":"5","author":"Ang-Tiu","year":"2012","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.286.6372.1169","article-title":"Seborrhoea is not a feature of seborrhoeic dermatitis","volume":"286","author":"Burton","year":"1983","journal-title":"British Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD009446.pub2-BIB0126|cit126","first-page":"32","article-title":"Adult Seborrheic Dermatitis: A Status Report on Practical Topical Management","volume":"4","author":"Rosso","year":"2011","journal-title":"The Journal of Clinical and Aesthetic Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009446.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archderm.139.3.318","article-title":"The frequency of common skin conditions in pre-school-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap)","volume":"139","author":"Foley","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1468-3083.2004.00693.x","article-title":"Seborrheic dermatitis","volume":"18","author":"Gupta","year":"2004","journal-title":"Journal of European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1067\/mjd.2003.274","article-title":"Ethnic skin disorders overview","volume":"48","author":"Halder","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD009446.pub2-BIB0130|cit130","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD009446.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/WOX.0b013e3181e2eb2e","article-title":"Dermatology for the allergist","volume":"3","author":"Kim","year":"2010","journal-title":"World Allergy Organization Journal"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMcp0806464","article-title":"Clinical practice. Seborrheic dermatitis","volume":"360","author":"Naldi","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009446.pub2-BIB0133|cit133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008138","article-title":"Interventions for seborrhoeic dermatitis","author":"Okokon","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009446.pub2-BIB0134|cit134","first-page":"125","article-title":"Seborrheic dermatitis: an overview","volume":"74","author":"Schwartz","year":"2006","journal-title":"American Family Physician"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009446.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T02:38:46Z","timestamp":1689215926000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009446.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,19]]},"references-count":134,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009446.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,19]]}}}